June 2022 tender notification
Pharmac is pleased to provide the latest tender results.
Download the tender notification [PDF 181 KB]
Tender results
Pharmac has resolved to award tenders for Principal Supply Status for some products included in the 2021/22 Invitation to Tender, dated 1 November 2021.
Some of the pharmaceuticals that will be delisted when the period of Principal Supply Status commences may be subject to existing listing contracts with Pharmac. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. Pharmac will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to submit a Notification of Product Changes (NOPC) form to Pharmac, the Pharmacy Guild and the NZULM by:
- For new listings, by 4pm on 12 July 2022 or the 5th of the month prior to listing, whichever is earlier
- For price changes, by 4pm on the 12th of the month prior to the date of subsidy change
Pharmac cannot list a product (and pharmacies cannot claim) without this information.
More information about this process and NOPC forms can be found on our website.
Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link).
Pharmacodes and CTPP codes must be provided to Pharmac by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest).
Pharmac cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.
2021/22 Tender – Principal Supply Status applies until 30 June 2025
Community Pharmaceutical tenders – Section B of the Pharmaceutical Schedule
1. Tenders awarded to currently listed Pharmaceuticals where no other brand is listed
|
Chemical name |
Presentation; |
Current |
New |
Principal Supply brand |
Date of subsidy change |
Principal Supply date |
|---|---|---|---|---|---|---|
|
Aciclovir |
Tab dispersible 200 mg; 25 tablet blister pack |
$1.60 |
$1.78 |
Lovir (Douglas) |
1 October 2022 |
1 March 2023 |
|
Aciclovir |
Tab dispersible 400 mg; 56 tablet blister pack |
$5.38 |
$5.81 |
Lovir (Douglas) |
1 November 2022 |
1 April 2023 |
|
Aciclovir |
Tab dispersible 800 mg; 35 tablet blister pack |
$5.98 |
$6.46 |
Lovir (Douglas) |
1 November 2022 |
1 April 2023 |
|
Azathioprine |
Tab 25 mg; 60 tablet blister pack |
$7.35 |
$7.36 |
Azamun (Douglas) |
1 November 2022 |
1 April 2023 |
|
Azathioprine |
Tab 50 mg; 100 tablet blister pack |
$7.60 |
$8.10 |
Azamun (Douglas) |
1 October 2022 |
1 March 2023 |
|
Cefalexin |
Cap 250 mg; 20 capsule blister pack |
$3.33 |
$3.85 |
Cephalexin ABM (Boucher) |
1 November 2022 |
1 April 2023 |
|
Cefalexin |
Cap 500 mg; 20 capsule blister pack |
$5.95 |
$5.85 |
Cephalexin ABM (Boucher) |
1 November 2022 |
1 April 2023 |
|
Clobetasol propionate |
Crm 0.05%; 30 g tube OP |
$2.18 |
$2.40 |
Dermol (Viatris) |
1 August 2022 |
1 January 2023 |
|
Clobetasol propionate |
Oint 0.05%; 30 g tube OP |
$2.12 |
$2.33 |
Dermol (Viatris) |
1 August 2022 |
1 January 2023 |
|
Clobetasol propionate |
Scalp app 0.05%; 30 ml bottle OP |
$5.69 |
$6.26 |
Dermol (Viatris) |
1 August 2022 |
1 January 2023 |
|
Clotrimazole |
Crm 1%; 20 g tube OP |
$0.77 |
$1.10 |
Clomazol (Multichem) |
1 November 2022 |
1 April 2023 |
|
Clotrimazole |
Vaginal crm 1% with applicators; 35 g pack OP |
$2.50 |
$3.50 |
Clomazol (Multichem) |
1 November 2022 |
1 April 2023 |
|
Clotrimazole |
Vaginal crm 2% with applicators; 20 g pack OP |
$3.00 |
$3.85 |
Clomazol (Multichem) |
1 November 2022 |
1 April 2023 |
|
Diazepam |
Rectal tubes 5 mg; 5 tube pack |
$43.50 |
$54.58 |
Stesolid (Teva) |
1 September 2022 |
1 February 2023 |
|
Digoxin |
Tab 62.5 mcg; 240 tablet blister pack |
$7.00 |
$7.80 |
Lanoxin PG (Aspen) |
1 August 2022 |
1 January 2023 |
|
Digoxin |
Tab 250 mcg; 240 tablet blister pack |
$15.20 |
$16.90 |
Lanoxin (Aspen) |
1 August 2022 |
1 January 2023 |
|
Ferrous sulfate |
Tab long-acting 325 mg (105 mg elemental); 30 |
$3.09 |
$2.55 |
Ferrograd (Viatris) |
1 August 2022 |
1 January 2023 |
|
Ferrous sulfate |
Oral liq 30 mg (6 mg elemental) per ml; 500 ml |
$12.08 |
$13.10 |
Ferodan (Viatris) |
1 August 2022 |
1 January 2023 |
|
Furosemide [Frusemide] |
Inj 10 mg per ml, 2 ml ampoule; 5 ampoule pack |
$1.15 |
$2.40 |
Furosemide-Baxter (Baxter) |
1 August 2022 |
1 January 2023 |
|
Intra-uterine device |
IUD 29.1 mm length x 23.2 mm width; 1 IUD pack |
$18.45 |
$29.80 |
Choice TT380 Short (Boucher) |
1 November 2022 |
1 April 2023 |
|
Intra-uterine device |
IUD 33.6 mm length x 29.9 mm width; 1 IUD pack |
$18.45 |
$29.80 |
Choice TT380 Standard |
1 November 2022 |
1 April 2023 |
|
Intra-uterine device |
IUD 35.5 mm length x 19.6 mm width; 1 IUD pack |
$15.50 |
$33.00 |
Choice Load 375 (Boucher) |
1 November 2022 |
1 April 2023 |
|
Lactulose |
Oral liq 10 g per 15 ml; 500 ml bottle |
$3.33 |
$3.61 |
Laevolac (Douglas) |
1 November 2022 |
1 April 2023 |
|
Lidocaine [lignocaine] |
Gel 2%, 11 ml urethral syringe; 10 syringe |
$42.00 |
$59.50 |
Instillagel Lido (Inter) |
1 August 2022 |
1 January 2023 |
|
Loperamide hydrochloride |
Cap 2 mg; 400 capsule blister pack |
$6.25 |
$7.25 |
Diamide Relief (Viatris) |
1 August 2022 |
1 January 2023 |
|
Loratadine |
Tab 10 mg; 100 tablet blister pack |
$1.69 |
$1.78 |
Lorafix (Teva) |
1 September 2022 |
1 February 2023 |
|
Morphine sulphate |
Cap long-acting 10 mg; 10 capsule blister pack |
$2.05 |
$3.00 |
m-Eslon (Multichem) |
1 November 2022 |
1 April 2023 |
|
Morphine sulphate |
Cap long-acting 30 mg; 10 capsule blister pack |
$3.00 |
$4.30 |
m-Eslon (Multichem) |
1 November 2022 |
1 April 2023 |
|
Morphine sulphate |
Cap long-acting 60 mg; 10 capsule blister pack |
$6.12 |
$9.00 |
m-Eslon (Multichem) |
1 November 2022 |
1 April 2023 |
|
Morphine sulphate |
Cap long-acting 100 mg; 10 capsule blister pack |
$7.13 |
$10.50 |
m-Eslon (Multichem) |
1 November 2022 |
1 April 2023 |
|
Omeprazole |
Inj 40 mg ampoule with diluent; 5 ampoule pack |
$33.98 |
$37.38 |
Dr Reddy’s Omeprazole |
1 August 2022 |
1 January 2023 |
|
Oxytocin |
Inj 5 iu per ml, 1 ml ampoule; 5 ampoule pack |
$3.98 |
$4.98 |
Oxytocin BNM (Boucher) |
1 January 2023 |
1 June 2023 |
|
Oxytocin |
Inj 10 iu per ml, 1 ml ampoule; 5 ampoule pack |
$4.98 |
$5.98 |
Oxytocin BNM (Boucher) |
1 January 2023 |
1 June 2023 |
|
Paracetamol with codeine |
Tab paracetamol 500 mg with codeine phosphate |
$26.51 |
$27.50 |
Paracetamol + Codeine |
1 August 2022 |
1 January 2023 |
|
Phenoxymethylpenicillin |
Grans for oral liq 125 mg per 5 ml; 100 ml bottle |
$2.99 |
$3.40 |
AFT (AFT) |
1 August 2022 |
1 January 2023 |
|
Phenoxymethykpenicillin |
Grans for oral liq 250 mg per 5 ml; 100 ml bottle |
$3.99 |
$4.24 |
AFT (AFT) |
1 August 2022 |
1 January 2023 |
|
Ropinirole hydrochloride |
Tab 2 mg; 84 tablet bottle |
$5.48 |
$6.48 |
Ropin (Viatris) |
1 August 2022 |
1 January 2023 |
|
Ropinirole hydrochloride |
Tab 5 mg; 84 tablet bottle |
$12.50 |
$14.50 |
Ropin (Viatris) |
1 August 2022 |
1 January 2023 |
|
Sodium chloride |
Inj 0.9%, 5 ml ampoule; 20 ampoule pack |
$2.80 |
$4.00 |
Fresenius Kabi |
1 August 2022 |
1 January 2023 |
|
Sodium chloride |
Inj 0.9%; 10 ml ampoule; 50 ampoule pack |
$5.40 |
$5.25 |
Fresenius Kabi |
1 August 2022 |
1 January 2023 |
|
Sodium chloride |
Inj 0.9%, 20 ml ampoule; 20 ampoule pack |
$5.00 |
$5.00 |
Fresenius Kabi |
1 August 2022 |
1 January 2023 |
|
Sodium citrate with sodium lauryl |
Enema 90 mg with sodium lauryl sulphoacetate |
$29.88 |
$35.89 |
Micolette (AFT) |
1 January 2023 |
1 June 2023 |
|
Sotalol |
Tab 80 mg; 500 tablet bottle |
$32.58 |
$37.50 |
Mylan (Viatris) |
1 August 2022 |
1 January 2023 |
|
Sotalol |
Tab 160 mg; 100 tablet bottle |
$10.98 |
$14.00 |
Mylan (Viatris) |
1 August 2022 |
1 January 2023 |
|
Sunscreens, proprietary |
Lotn; 200 g tube OP |
$5.10 |
$6.50 |
Marine Blue Lotion SPF 50+ |
1 November 2022 |
1 April 2023 |
|
Tamsulosin |
Cap 400 mcg; 100 capsule blister pack |
$17.73 |
$22.31 |
Tamsulosin-Rex |
1 August 2022 |
1 January 2023 |
|
Tenoxicam |
Tab 20 mg; 100 tablet blister pack |
$9.15 |
$18.50 |
Tilcotil (Viatris) |
1 August 2022 |
1 January 2023 |
|
Tetrabenazine |
Tab 25 mg; 112 tablet bottle |
$91.10 |
$106.59 |
Motetis (Douglas) |
1 November 2022 |
1 April 2023 |
|
Tranexamic acid |
Tab 500 mg; 60 tablet blister pack |
$9.45 |
$10.45 |
Mercury Pharma (Boucher) |
1 January 2023 |
1 June 2023 |
2. Tenders awarded to Pharmaceuticals where at least one other brand is listed
|
Chemical name |
Presentation; |
Current |
New |
Principal Supply brand (Supplier) |
Date of listing |
Principal Supply Status date |
Brand |
|---|---|---|---|---|---|---|---|
|
Abacavir sulphate with |
Tab 600 mg with lamivudine |
$63.00 |
$29.50 |
Abacavir/Lamivudine Viatris (Viatris) |
1 December 2022 |
1 May 2023 |
Kivexa (GSK) |
|
Ascorbic acid |
Tab 100 mg; 500 tablet bottle |
$9.90 |
$12.50 |
CVite (Evara) |
1 September 2022 |
1 February 2023 |
CVite (Boucher) |
|
Cefaclor monohydrate |
Cap 250 mg; 100 capsule bottle |
$24.70 |
$25.85 |
Ranbaxy-Cefaclor (Douglas) |
1 November 2022 |
1 April 2023 |
Ranbaxy-Cefaclor S29 (Douglas) |
|
Cefaclor monohydrate |
Grans for oral liq 125 mg per 5 ml; |
$3.53 |
$3.75 |
Ranbaxy-Cefaclor (Douglas) |
1 November 2022 |
1 April 2023 |
Ranbaxy-Cefaclor S29 (Douglas) |
|
Chloramphenicol |
Eye drops 0.5%; 10 ml dropper |
$1.54 |
$1.45 |
Chlorsig (Aspen) |
1 April 2023 |
1 September 2023 |
Chlorafast (Teva) |
|
Clopidogrel |
Tab 75 mg; 84 tablet blister pack |
$4.60 |
$5.07 |
Arrow-Clopid (Teva) |
1 December 2022 |
1 May 2023 |
Clopidogrel Multichem |
|
Diltiazem hydrochloride |
Cap long-acting 120 mg; |
$44.40 |
$65.35 |
Diltiazem CD Clinect (Clinect) |
1 January 2023 |
1 June 2023 |
Accord (Link Pharmaceuticals) Apo-Diltiazem CD (Apotex) |
|
Glycopyrronium bromide |
Inj 200 mcg per ml, 1 ml ampoule; |
$65.45 |
$19.00 |
Robinul (Aspen) |
1 April 2023 |
1 September 2023 |
Max Health (Max Health) |
|
Heparin sodium2 |
Inj 5,000 iu per ml, 5 ml vial; |
$289.05 |
$83.00 |
Heparin Sodium Panpharma |
1 February 2023 |
1 July 2023 |
Pfizer (Pfizer) |
|
Iloprost3 |
Nebuliser soln 10 mcg per ml, |
$740.10 |
$185.03 |
Vebulis (Devatis) |
1 October 2022 |
1 March 2023 |
Ventavis (Bayer) |
|
Morphine sulphate |
Inj 5 mg per ml, 1 ml ampoule; |
$6.99 |
$5.38 |
Medsurge (Medsurge) |
1 October 2022 |
1 March 2023 |
DBL Morphine Sulphate (Pfizer) |
|
Morphine sulphate |
Inj 10 mg per ml, 1 ml ampoule; |
$5.61 |
$4.68 |
Medsurge (Medsurge) |
1 October 2022 |
1 March 2023 |
DBL Morphine Sulphate (Pfizer) |
|
Morphine sulphate |
Inj 15 mg per ml, 1 ml ampoule; |
$7.08 |
$5.53 |
Medsurge (Medsurge) |
1 October 2022 |
1 March 2023 |
DBL Morphine Sulphate (Pfizer) |
|
Morphine sulphate |
Inj 30 mg per ml, 1 ml ampoule; |
$7.28 |
$6.28 |
Medsurge (Medsurge) |
1 October 2022 |
1 March 2023 |
DBL Morphine Sulphate (Pfizer) |
|
Multivitamins |
Tab (BPC cap strength); |
$11.45 |
$18.50 |
MVite (Evara) |
1 September 2022 |
1 February 2023 |
MVite (Boucher) |
|
Paroxetine |
Tab 20 mg; 90 tablet blister pack |
$3.61 |
$4.11 |
Loxamine (Viatris) |
1 August 2022 |
1 January 2023 |
Loxamine (Viatris) Pharmacode 2626799 |
|
Pegfilgrastim4 |
Inj 6 mg per 0.6 ml syringe; |
$1080.00 |
$65.00 |
Ziextenzo (Sandoz) |
1 January 2023 |
1 June 2023 |
Neulastim (Amgen) |
|
Ropinirole hydrochloride |
Tab 0.25 mg; 84 tablet bottle |
$2.85 |
$4.05 |
Ropin (Viatris) |
1 August 2022 |
1 January 2023 |
Mylan (Viatris) |
|
Ropinirole hydrochloride |
Tab 1 mg; 84 tablet bottle |
$3.95 |
$4.95 |
Ropin (Viatris) |
1 August 2022 |
1 January 2023 |
Mylan (Viatris)5 |
|
Water |
Inj 20 ml ampoule; |
$5.00 |
$5.00 |
Fresenius Kabi |
1 August 2022 |
1 January 2023 |
Multichem (Multichem) |
|
Zoledronic acid |
Inj 0.05 mg per ml, 100 ml bag |
$60.00 |
$22.53 |
Zoledronic Acid |
1 January 2023 |
1 June 2023 |
Aclasta (Novartis) |
|
1Brand Switch Fee of $4.50 is payable for this product from 1 May 2023 to 31 July 2023. 2Brand Switch Fee of $4.50 is payable for this product from 1 July 2023 to 30 September 2023. 3Brand Switch Fee of $4.50 is payable for this product from 1 March 2023 to 31 May 2023. 4 Brand Switch Fee of $4.50 is payable for this product from 1 June 2023 to 31 August 2023. Please note funding criteria for pegfilgrastim is subject to further consideration by Pharmac, in awarding this tender Pharmac reserves its right to amend funding criteria as outlined in the 2021/22 Invitation to Tender notification.(external link) 5Mylan S29 (Pharmacode 2579804) to be delisted 1 December 2022. |
|||||||
See table 3 below for changes to Section B of the Pharmaceutical Schedule in relation to fludarabine phosphate.
Hospital Pharmaceutical tenders – Section H of the Pharmaceutical Schedule
3. Tenders awarded to Pharmaceuticals where no other brand is listed
|
Chemical name |
Presentation; |
Current |
New |
Principal Supply brand |
DV |
Date of price change |
Principal Supply date |
|---|---|---|---|---|---|---|---|
|
Aciclovir |
Tab dispersible 200 mg; 25 tablet |
$1.60 |
$1.78 |
Lovir (Douglas) |
5% |
1 October 2022 |
1 March 2023 |
|
Aciclovir |
Tab dispersible 400 mg; 56 tablet |
$5.38 |
$5.81 |
Lovir (Douglas) |
5% |
1 November 2022 |
1 April 2023 |
|
Aciclovir |
Tab dispersible 800 mg; 35 tablet |
$5.98 |
$6.46 |
Lovir (Douglas) |
5% |
1 November 2022 |
1 April 2023 |
|
Azathioprine |
Tab 25 mg; 60 tablet blister pack |
$7.35 |
$7.36 |
Azamun (Douglas) |
5% |
1 November 2022 |
1 April 2023 |
|
Azathioprine |
Tab 50 mg; 100 tablet blister pack |
$7.60 |
$8.10 |
Azamun (Douglas) |
5% |
1 October 2022 |
1 March 2023 |
|
Cefaclor |
Cap 250 mg; 100 capsule bottle |
$24.70 |
$25.85 |
Ranbaxy-Cefaclor |
5% |
1 November 2022 |
1 April 2023 |
|
Cefaclor |
Grans for oral liq 25 mg per ml; |
$3.53 |
$3.75 |
Ranbaxy-Cefaclor |
5% |
1 November 2022 |
1 April 2023 |
|
Cefalexin |
Cap 250 mg; 20 capsule |
$3.33 |
$3.85 |
Cephalexin ABM (Boucher) |
5% |
1 November 2022 |
1 April 2023 |
|
Cefalexin |
Cap 500 mg; 20 capsule |
$5.95 |
$5.85 |
Cephalexin ABM (Boucher) |
5% |
1 November 2022 |
1 April 2023 |
|
Clobetasol propionate |
Crm 0.05%; 30 g tube |
$2.18 |
$2.40 |
Dermol (Viatris) |
5% |
1 August 2022 |
1 January 2023 |
|
Clobetasol propionate |
Oint 0.05%; 30 g tube |
$2.12 |
$2.33 |
Dermol (Viatris) |
5% |
1 August 2022 |
1 January 2023 |
|
Clobetasol propionate |
Scalp app 0.05%; 30 ml bottle |
$5.69 |
$6.26 |
Dermol (Viatris) |
5% |
1 August 2022 |
1 January 2023 |
|
Clotrimazole |
Vaginal crm 1% with applicators; |
$2.50 |
$3.50 |
Clomazol (Multichem) |
5% |
1 November 2022 |
1 April 2023 |
|
Clotrimazole |
Vaginal crm 2% with applicators; |
$3.00 |
$3.85 |
Clomazol (Multichem) |
5% |
1 November 2022 |
1 April 2023 |
|
Clotrimazole |
Crm 1%; 20 g tube |
$0.77 |
$1.10 |
Clomazol (Multichem) |
5% |
1 November 2022 |
1 April 2023 |
|
Diazepam |
Rectal tubes 5 mg; 5 tube pack |
$43.50 |
$54.58 |
Stesolid (Teva) |
5% |
1 September 2022 |
1 February 2023 |
|
Digoxin |
Tab 62.5 mcg; 240 tablet blister |
$7.00 |
$7.80 |
Lanoxin PG (Aspen) |
5% |
1 August 2022 |
1 January 2023 |
|
Digoxin |
Tab 250 mcg; 240 tablet blister |
$15.20 |
$16.90 |
Lanoxin (Aspen) |
5% |
1 August 2022 |
1 January 2023 |
|
Ferrous sulfate |
Tab long-acting 325 mg (105 mg |
$3.09 |
$2.55 |
Ferrograd (Viatris) |
5% |
1 August 2022 |
1 January 2023 |
|
Ferrous sulfate |
Oral liq 30 mg (6 mg elemental) |
$12.08 |
$13.10 |
Ferodan (Viatris) |
5% |
1 August 2022 |
1 January 2023 |
|
Fludarabine phosphate6 |
Inj 50 mg vial; 5 vial pack |
$576.45 |
$634.00 |
Fludarabine Ebewe |
5% |
1 August 2022 |
1 January 2023 |
|
Furosemide [Frusemide] |
Inj 10 mg per ml, 2 ml ampoule; |
$1.15 |
$2.40 |
Furosemide-Baxter |
5% |
1 August 2022 |
1 January 2023 |
|
Intra-uterine device |
IUD 29.1 mm length x 23.2 mm |
$18.45 |
$29.80 |
Choice TT380 Short |
5% |
1 November 2022 |
1 April 2023 |
|
Intra-uterine device |
IUD 33.6 mm length x 29.9 mm |
$18.45 |
$29.80 |
Choice TT380 Standard |
5% |
1 November 2022 |
1 April 2023 |
|
Intra-uterine device |
IUD 35.5 mm length x 19.6 mm |
$15.50 |
$33.00 |
Choice Load 375 (Boucher) |
5% |
1 November 2022 |
1 April 2023 |
|
Lactulose |
Oral liq 10 g per 15 ml; 500 ml |
$3.33 |
$3.61 |
Laevolac (Douglas) |
5% |
1 November 2022 |
1 April 2023 |
|
Lidocaine [Lignocaine] |
Gel 2%, 11 ml urethral syringe; |
$42.00 |
$59.50 |
Instillagel Lido |
5% |
1 August 2022 |
1 January 2023 |
|
Lidocaine [lignocaine] |
Spray 10%; 50 ml spray bottle |
$75.00 |
$78.95 |
Xylocaine (Aspen) |
5% |
1 August 2022 |
1 January 2023 |
|
Lidocaine [lignocaine] |
Inj 1% with adrenaline 1:100,000. |
$29.00 |
$32.00 |
Xylocaine (Aspen) |
5% |
1 August 2022 |
1 January 2023 |
|
Loperamide hydrochloride |
Cap 2 mg; 400 capsule blister |
$6.25 |
$7.25 |
Diamide Relief (Viatris) |
5% |
1 August 2022 |
1 January 2023 |
|
Loratadine |
Tab 10 mg; 100 tablet blister |
$1.69 |
$1.78 |
Lorafix (Teva) |
5% |
1 September 2022 |
1 February 2023 |
|
Morphine sulphate |
Cap long-acting 10 mg; 10 |
$2.05 |
$3.00 |
m-Eslon (Multichem) |
5% |
1 November 2022 |
1 April 2023 |
|
Morphine sulphate |
Cap long-acting 30 mg; 10 |
$3.00 |
$4.30 |
m-Eslon (Multichem) |
5% |
1 November 2022 |
1 April 2023 |
|
Morphine sulphate |
Cap long-acting 60 mg; 10 |
$6.12 |
$9.00 |
m-Eslon (Multichem) |
5% |
1 November 2022 |
1 April 2023 |
|
Morphine sulphate |
Cap long-acting 100 mg; 10 |
$7.13 |
$10.50 |
m-Eslon (Multichem) |
5% |
1 November 2022 |
1 April 2023 |
|
Omeprazole |
Inj 40 mg ampoule with diluent; |
$33.98 |
$37.38 |
Dr Reddy’s Omeprazole |
5% |
1 August 2022 |
1 January 2023 |
|
Omeprazole |
Inj 40 mg vial; 5 vial pack |
$11.46 |
$11.95 |
Omezol IV (Viatris) |
5% |
1 August 2022 |
1 January 2023 |
|
Oxytocin |
Inj 5 iu per ml, 1 ml ampoule; |
$3.98 |
$4.98 |
Oxytocin BNM |
5% |
1 January 2023 |
1 June 2023 |
|
Oxytocin |
Inj 10 iu per ml, 1 ml ampoule; |
$4.98 |
$5.98 |
Oxytocin BNM |
5% |
1 January 2023 |
1 June 2023 |
|
Paracetamol with codeine |
Tab paracetamol 500 mg with |
$26.51 |
$27.50 |
Paracetamol + Codeine |
5% |
1 August 2022 |
1 January 2023 |
|
Phenoxymethylpenicillin |
Grans for oral liq 125 mg per 5 |
$2.99 |
$3.40 |
AFT (AFT) |
5% |
1 August 2022 |
1 January 2023 |
|
Phenoxymethylpenicillin |
Grans for oral liq 250 mg per 5 |
$3.99 |
$4.24 |
AFT (AFT) |
5% |
1 August 2022 |
1 January 2023 |
|
Propofol |
Inj 10 mg per ml, 20 ml ampoule; |
$4.35 |
$4.35 |
Fresofol 1% MCT/LCT |
10% |
1 August 2022 |
1 January 2023 |
|
Propofol |
Inj 10 mg per ml, 50 ml vial; 10 |
$19.50 |
$19.50 |
Fresofol 1% MCT/LCT |
10% |
1 August 2022 |
1 January 2023 |
|
Propofol |
Inj 10 mg per ml, 100 ml vial; 10 vial pack |
$39.00 |
$39.00 |
Fresofol 1% MCT/LCT |
10% |
1 August 2022 |
1 January 2023 |
|
Rocuronium bromide |
Inj 10 mg per ml, 5 ml ampoule; |
$31.14 |
$37.06 |
Hameln (Max Health) |
10% |
1 August 2022 |
1 January 2023 |
|
Ropinirole hydrochloride |
Tab 0.25 mg; 84 tablet bottle |
$2.85 |
$4.05 |
Ropin (Viatris) |
5% |
1 August 2022 |
1 January 2023 |
|
Ropinirole hydrochloride |
Tab 1 mg; 84 tablet bottle |
$3.95 |
$4.95 |
Ropin (Viatris) |
5% |
1 August 2022 |
1 January 2023 |
|
Ropinirole hydrochloride |
Tab 2 mg; 84 tablet bottle |
$5.48 |
$6.48 |
Ropin (Viatris) |
5% |
1 August 2022 |
1 January 2023 |
|
Ropinirole hydrochloride |
Tab 5 mg; 84 tablet bottle |
$12.50 |
$14.50 |
Ropin (Viatris) |
5% |
1 August 2022 |
1 January 2023 |
|
Sodium chloride |
Inj 0.9%, 5 ml ampoule; 20 |
$2.80 |
$4.00 |
Fresenius Kabi |
5% |
1 August 2022 |
1 January 2023 |
|
Sodium chloride |
Inj 0.9%, 10 ml ampoule; |
$5.40 |
$5.25 |
Fresenius Kabi |
5% |
1 August 2022 |
1 January 2023 |
|
Sodium chloride |
Inj 0.9%, 20 ml ampoule; 20 |
$5.00 |
$5.00 |
Fresenius Kabi |
5% |
1 August 2022 |
1 January 2023 |
|
Sodium citrate with sodium lauryl |
Enema 90 mg with sodium lauryl |
$29.98 |
$35.89 |
Micolette (AFT) |
5% |
1 January 2023 |
1 June 2023 |
|
Sotalol |
Tab 80 mg; 500 tablet bottle |
$32.58 |
$37.50 |
Mylan (Viatris) |
5% |
1 August 2022 |
1 January 2023 |
|
Sotalol |
Tab 160 mg; 100 tablet bottle |
$10.98 |
$14.00 |
Mylan (Viatris) |
5% |
1 August 2022 |
1 January 2023 |
|
Sunscreens, proprietary |
Lotn; 200 g tube |
$5.10 |
$6.50 |
Marine Blue Lotion |
5% |
1 November 2022 |
1 April 2023 |
|
Tamsulosin |
Cap 400 mcg; 100 capsule |
$17.73 |
$22.31 |
Tamsulosin-Rex |
5% |
1 August 2022 |
1 January 2023 |
|
Tenoxicam |
Tab 20 mg; 100 tablet blister pack |
$9.15 |
$18.50 |
Tilcotil (Viatris) |
5% |
1 August 2022 |
1 January 2023 |
|
Tetrabenazine |
Tab 25 mg; 112 tablet bottle |
$91.10 |
$106.59 |
Motetis (Douglas) |
5% |
1 November 2022 |
1 April 2023 |
|
Tranexamic acid |
Tab 500 mg; 60 tablet blister pack |
$9.45 |
$10.45 |
Mercury Pharma (Boucher) |
5% |
1 January 2023 |
1 June 2023 |
|
6The price and subsidy of fludarabine phosphate (PCT only – Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 August 2022. The subsidy of fludarabine phosphate (Baxter) inj will also be amended from $115.29 per 50 mg OP to $126.80 per 50 mg OP from 1 August 2022. |
|||||||
4. Tenders awarded to Pharmaceuticals where at least one other brand is listed
|
Chemical name |
Presentation; |
Current pack price |
New pack price |
Principal Supply brand |
DV limit |
Listing date |
Principal Supply date |
Brand (Supplier) affected by delisting |
|---|---|---|---|---|---|---|---|---|
|
Abacavir sulphate with |
Tab 600 mg with lamivudine |
$63.00 |
$29.50 |
Abacavir/Lamivudine |
5% |
1 December 2022 |
1 May 2023 |
Kivexa (GSK) |
|
Ascorbic acid |
Tab 100 mg; 500 tablet bottle |
$9.90 |
$12.50 |
CVite (Evara) |
5% |
1 September 2022 |
1 February 2023 |
CVite (Boucher) |
|
Bupivacaine hydrochloride |
Inj 1.25 mg with fentanyl 2 mcg |
$112.50 |
$245.00 |
Bupafen (Biomed) |
5% |
1 August 2022 |
1 January 2023 |
Bupafen (Biomed) |
|
Bupivacaine hydrochloride |
Inj 1.25 mg with fentanyl 2 mcg |
$117.50 |
$255.00 |
Bupafen (Biomed) |
5% |
1 August 2022 |
1 January 2023 |
Bupafen (Biomed) |
|
Caspofungin |
Inj 50 mg vial; 1 vial pack |
$220.28 |
$110.00 |
Alchemy Caspofungin |
5% |
1 November 2022 |
1 April 2023 |
Max Health (Max Health) |
|
Caspofungin |
Inj 70 mg vial; 1 vial pack |
$284.63 |
$135.00 |
Alchemy Caspofungin |
5% |
1 November 2022 |
1 April 2023 |
Max Health (Max Health) |
|
Chloramphenicol |
Eye drops 0.5%; 10 ml dropper |
$1.54 |
$1.45 |
Chlorsig (Aspen) |
5% |
1 April 2023 |
1 September 2023 |
Chlorafast (Teva) |
|
Clopidogrel |
Tab 75 mg; 84 tablet blister |
$4.60 |
$5.07 |
Arrow-Clopid (Teva) |
5% |
1 December 2022 |
1 May 2023 |
Clopidogrel Multichem |
|
Diltiazem hydrochloride |
Cap long-acting 120 mg; 500 |
$44.40 |
$65.35 |
Diltiazem CD Clinect |
5% |
1 January 2023 |
1 June 2023 |
Accord
Apo-Diltiazem CD |
|
Glycopyrronium bromide |
Inj 200 mcg per ml, 1 ml |
$65.45 |
$19.00 |
Robinul (Aspen) |
5% |
1 April 2023 |
1 September 2023 |
Max Health (Max Health) |
|
Heparin sodium |
Inj 5,000 iu per ml, 5 ml vial; |
$289.05 |
$83.00 |
Heparin Sodium |
5% |
1 February 2023 |
1 July 2023 |
Pfizer (Pfizer) |
|
Iloprost |
Nebuliser soln 10 mcg per ml, |
$740.10 |
$185.03 |
Vebulis (Devatis) |
5% |
1 October 2022 |
1 March 2023 |
Ventavis (Bayer) |
|
Morphine sulphate |
Inj 5 mg per ml, 1 ml ampoule; |
$6.99 |
$5.38 |
Medsurge (Medsurge) |
5% |
1 October 2022 |
1 March 2023 |
DBL Morphine Sulphate |
|
Morphine sulphate |
Inj 10 mg per ml, 1 ml ampoule; |
$5.61 |
$4.68 |
Medsurge (Medsurge) |
5% |
1 October 2022 |
1 March 2023 |
DBL Morphine Sulphate |
|
Morphine sulphate |
Inj 15 mg per ml, 1 ml ampoule; |
$7.08 |
$5.53 |
Medsurge (Medsurge) |
5% |
1 October 2022 |
1 March 2023 |
DBL Morphine Sulphate |
|
Morphine sulphate |
Inj 30 mg per ml, 1 ml ampoule; |
$7.28 |
$6.28 |
Medsurge (Medsurge) |
5% |
1 October 2022 |
1 March 2023 |
DBL Morphine Sulphate |
|
Multivitamins |
Tab (BPC cap strength); 1,000 |
$11.45 |
$18.50 |
MVite (Evara) |
5% |
1 September 2022 |
1 March 2023 |
MVite (Boucher) |
|
Paroxetine |
Tab 20 mg; 90 tablet blister |
$3.61 |
$4.11 |
Loxamine (Viatris) |
5% |
1 August 2022 |
1 January 2023 |
Loxamine (Viatris) |
|
Pegfilgrastim7 |
Inj 6 mg per 0.6 ml syringe; 1 |
$1080.00 |
$65.00 |
Ziextenzo (Sandoz) |
5% |
1 January 2023 |
1 June 2023 |
Neulastim (Amgen) |
|
Sodium chloride |
Inj 0.9% 3 ml syringe, non-sterile |
$168.00 |
$12.00 |
BD Posiflush (BD) |
5% |
1 October 2022 |
1 March 2023 |
BD Posiflush (BD) |
|
Sodium chloride |
Inj 0.9% 5 ml syringe, non-sterile |
$169.92 |
$12.00 |
BD Posiflush (BD) |
5% |
1 October 2022 |
1 March 2023 |
BD Posiflush (BD) |
|
Sodium chloride |
Inj 0.9% 10 ml syringe, |
$177.60 |
$11.70 |
BD Posiflush (BD) |
5% |
1 October 2022 |
1 March 2023 |
BD Posiflush (BD) |
|
Water |
Inj 20 ml ampoule; 20 ampoule |
$5.00 |
$5.00 |
Fresenius Kabi |
5% |
1 August 2022 |
1 January 2023 |
Multichem (Multichem) |
|
Zoledronic acid |
Inj 0.05 mg per ml, 100 ml, vial |
$60.00 |
$22.53 |
Zoledronic Acid Viatris |
5% |
1 January 2023 |
1 June 2023 |
Aclasta (Novartis) |
|
7Please note funding criteria for pegfilgrastim is subject to further consideration by Pharmac, in awarding this tender Pharmac reserves its right to amend funding criteria as outlined in the 2021/22 Invitation to Tender notification.(external link) |
||||||||
Tender declines - Products where no tender is to be awarded for Principal Supply Status
Pharmac has resolved not to award tenders for Principal Supply Status for the following products listed in the:
- 2020/21 Invitation to Tender, dated 2 November 2020
- 2021/22 Invitation to Tender, dated 1 November 2021
2020/21 Invitation to Tender
|
Chemical name |
Line item |
|---|---|
|
Dapsone |
Tab 100 mg |
|
Ethambutol |
Tab 400 mg |
|
Fosfomycin (current access) |
Powder |
|
Fosfomycin (widened access) |
Powder |
|
Noradrenaline |
Inj 0.06 mg per ml, 50 ml syringe |
|
Noradrenaline |
Inj 0.1 mg per ml, 100 ml bag |
|
Noradrenaline |
Inj 0.12 mg per ml, 100 ml bag |
|
Noradrenaline |
Inj 0.16 mg per ml, 50 ml syringe |
|
Prednisolone |
Rectal Foam 10 – 20% |
2021/22 Invitation to Tender
|
Chemical name |
Line item |
|---|---|
|
Acetazolamide |
Inj 500 mg |
|
Alendronate sodium |
Tab 70 mg |
|
Alendronate sodium with colecalciferol |
Tab 70 mg with colecalciferol 5,600 iu |
|
Atomoxetine |
Cap 100 mg |
|
Aspirin |
Tab 100 mg EC |
|
Aspirin |
Tab soluble or dispersible 300 mg |
|
Azathioprine |
Inj 50 mg |
|
Bupivacaine hydrochloride with adrenaline |
Inj 0.25% with 1:400,000 of adrenaline, 20 ml |
|
Bupivacaine hydrochloride with adrenaline |
Inj 0.5% with 1:200,000 of adrenaline, 20 ml |
|
Bupivacaine hydrochloride with fentanyl |
Inj 0.625 mg with fentanyl 2 mcg per ml, |
|
Diazepam |
Rectal tubes 10 mg |
|
Diltiazem hydrochloride |
Tab 60 mg |
|
Dimethicone |
Crm 10% |
|
Heparin sodium |
Inj 1,000 iu per ml, 1 ml |
|
Heparin sodium |
Inj 1,000 iu per ml, 5 ml |
|
Heparin sodium |
Inj 100 iu per ml, 250 ml bag |
|
Heparin sodium |
Inj 25,000 iu per ml, 0.2 ml |
|
Heparin sodium |
Inj 5,000 iu per ml, 1 ml |
|
Iloprost |
Inj 50 mcg per ml, 0.5 ml |
|
Levothyroxine |
Oral liq |
|
Lidocaine [lignocaine] hydrochloride |
Inj 1%, 20 ml |
|
Lidocaine [lignocaine] hydrochloride |
Inj 1%, 5 ml |
|
Lidocaine [lignocaine] hydrochloride |
Inj 2%, 20 ml |
|
Lidocaine [lignocaine] hydrochloride |
Inj 2%, 5 ml |
|
Lidocaine [Lignocaine] hydrochloride |
Inj 10% |
|
Lidocaine [Lignocaine] hydrochloride |
Inj 10%, prefilled syringe |
|
Long-acting filgrastim (current access) |
Inj 6 mg per 0.6 ml syringe |
|
Loperamide hydrochloride |
Tab 2 mg |
|
Methadone hydrochloride |
Tab 10 mg |
|
Methylcellulose |
Suspension |
|
Metoprolol tartrate |
Inj 1 mg per 5 ml |
|
Olanzapine |
Inj 210 mg vial |
|
Olanzapine |
Inj 300 mg vial |
|
Olanzapine |
Inj 405 mg vial |
|
Paraffin |
White soft (pack size 500 g or less) |
|
Paraffin |
White soft (pack size 2000 g or more) |
|
Prasugrel |
Tab 5 mg |
|
Prasugrel |
Tab 10 mg |
|
Sucrose |
Oral liq 25% |
|
Sulfasalazine |
Tab EC 500 mg |
|
Tolterodine tartrate |
Tab 1 mg |
|
Tolterodine tartrate |
Tab 2 mg |
|
Water for injection |
Purified for inj, 5 ml |
|
Zinc and castor oil |
Crm (pack size 50 g or less) |
|
Zinc sulphate |
Cap 50 mg elemental |
|
Zoledronic acid (widened access) |
Inj 5 mg |
|
Zonisamide |
Cap 25 mg |
|
Zonisamide |
Cap 50 mg |
|
Zonisamide |
Cap 100 mg |
For products included in the 2019/20, 2020/21 or 2021/22 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to Pharmac Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.
If you have any queries regarding this notification, please contact Pharmac on 0800 66 00 50.